Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bonofill-2 autologous cell therapy for oral and jaw bone defect filling
MOH_2019-09-27_007421Phase 2Recruiting
- Sponsor
- Bonus Therapeutics
- Start
- Aug 2016
- Modality
- Stem Cell Therapies → Cell Therapies, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of BonoFill-II in maxillofacial bone defect and Jawbone defect, sponsored by Bonus Therapeutics. Started Aug 2016; status: recruiting.
02
Drugs
BonoFill-II
03
Conditions
maxillofacial bone defectJawbone defect
Beyond the preview
Go deeper on MOH_2019-09-27_007421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-09-27_007421.